Cleared Traditional

K840033 - HYPODERMIC NEEDLES & STYLETS

K840033 is the FDA 510(k) clearance for HYPODERMIC NEEDLES & STYLETS by Microvasive. It is a Class 2 General Hospital device (product code FMI) cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K840033 · Microvasive · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1984
Decision
91d
Days
Class 2
Risk

K840033 is an FDA 510(k) clearance for the HYPODERMIC NEEDLES & STYLETS. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Microvasive (Mchenry, US). The FDA issued a Cleared decision on April 5, 1984 after a review of 91 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Microvasive devices

Submission Details

510(k) Number K840033 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 1984
Decision Date April 05, 1984
Days to Decision 91 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 129d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 249
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K840033.
CHURCHILL HABER POINT NEEDLE ADMIN. SET
K850420 · Churchill Corp. · Apr 1985
MONOJECT MENGHINI SOFT TISSUE BIOPSY
K843264 · Sherwood Medical Co. · Dec 1984
AMER. PHARMASEAL CHEMONUCLEOLYSIS TRAY
K842542 · American Pharmaseal Div. Ahsc · Aug 1984
OHIO HEAT REFLECTING PATCH
K840967 · Ohio Medical Products · Mar 1984
INTRADISCAL THERAPY TRAY
K834553 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Mar 1984
NEONATAL LUMBAR PUNCTURE TRAY
K832556 · American Pharmaseal Div. Ahsc · Sep 1983